Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people starting Mounjaro do report symptoms that feel a bit like the flu — fatigue, headache, muscle aches, and a general sense of feeling off — particularly in the first few days after a new dose. These reactions are real, they're recognised, and they have a straightforward explanation. They're also, for most people, temporary. Mounjaro (tirzepatide) is a prescription-only weight-management medicine that works on gut-hormone receptors involved in appetite and blood-sugar regulation; as your body adapts, some of that adaptation can feel a little rough. Understanding what's happening, and how long it tends to last, makes it much easier to get through.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The flu-like sensation that some people notice on Mounjaro isn't coincidence. Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) and one of the downstream effects is that the stomach empties more slowly. That slowing can trigger nausea, but the signalling also touches systems involved in energy regulation, which is why some people feel fatigued or achy in a way that resembles the early hours of a cold.
Headache is another common complaint, and dehydration plays a part here: if nausea has put you off drinking enough water, a headache almost inevitably follows. The same pattern can amplify the feeling that something viral is going on, when what's actually happening is your body recalibrating to a new hormonal signal.
The NHS medicines page for tirzepatide lists fatigue, headache, and dizziness alongside the more familiar gastrointestinal complaints. They're not a sign that treatment is failing, they're a sign it's working on a system your body hasn't experienced before. What Mounjaro actually feels like day to day varies considerably from person to person, but that first-week grogginess is a thread that runs through many people's experiences.
Muscle aches are less universal but do occur. Again, the mechanism is more likely hormonal and hydration-related than anything resembling true influenza, you won't have a fever, and you won't be contagious.
This is the question most people actually want answered, and the honest answer is: usually a few days per dose, most noticeably at the start of treatment and after each step up in strength.
Tirzepatide is introduced at 2.5 mg, a tolerability dose whose job is to let your system find its feet before the dose increases. Even so, some people feel tired or headachy for a day or two after their first injection. When the dose increases to 5 mg, there can be a second wave of adjustment. Each new step carries a small risk of another few days of feeling below par, though many people find subsequent increases easier than the first.
By around two to four weeks into any given dose, the majority of people have settled. The broader picture of how Mounjaro affects how you feel tends to shift from adjustment discomfort to a more noticeable reduction in appetite, which most people find far easier to manage. If symptoms that feel flu-like are still present and significant after three or four weeks without any dose change, that warrants a conversation with your prescriber rather than waiting it out.
It's also worth noting that actual flu (the viral kind) is a separate consideration entirely. If you're on Mounjaro and you come down with a genuine infection, that's a different situation, and there are specific things to consider about taking Mounjaro when you're ill that are worth reading before you reach for your next pen.
There are practical steps that genuinely reduce the intensity of adjustment symptoms. Staying well hydrated is the single most useful thing, a 500 ml glass of water before your evening meal won't replace the electrolytes lost through nausea, but it's a start. Some people find that injecting last thing at night means the worst of the fatigue and nausea passes during sleep; others prefer mornings. There's no clinical rule about timing, so this is about finding what works for you.
Eating smaller portions more frequently, avoiding very fatty or rich foods in the first few days after a dose, and not skipping meals entirely (even if appetite is low) all help blunt the GI effects that feed into that run-down feeling. The appetite-suppressing effect is real, but eating too little on top of nausea can worsen fatigue significantly.
As for when to get medical help: flu-like fatigue and headache are one thing; severe, persistent stomach pain that radiates into your back is another. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known (and serious) side effect of GLP-1 medicines, including tirzepatide. That symptom pattern needs urgent assessment, not a hot water bottle. Similarly, any signs of a severe allergic reaction (swelling, difficulty breathing, rash) require emergency help immediately. For anything that worries you in the ordinary run of treatment, the Yellow Card scheme at yellowcard.mhra.gov.uk is also the right place to report suspected side effects.
If you're considering starting treatment and want to understand what to expect, our tirzepatide overview covers the clinical picture in more detail. Questions about cost and what's included in a private prescription are addressed on our Mounjaro pricing page. And if you'd simply like to speak to someone on our clinical team, our lead prescriber's profile gives a sense of who reviews your consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.